(Q34677226)

3 August 2017

1 reference

title

Endocrine abnormalities in chronic renal failure (English)

1 reference

3 August 2017

Sean F Leavey

1

1 reference

PubMed ID

12055983

3 August 2017

William F Weitzel

series ordinal

2

1 reference

3 August 2017

1 March 2002

1 reference

Endocrinology and Metabolism Clinics of North America

3 August 2017

1 reference

3 August 2017

31

1 reference

3 August 2017

1

1 reference

3 August 2017

107-119

1 reference

A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Erythropoietin production: evidence for multiple oxygen sensing pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Epidemiology of renal osteodystrophy in Iberoamerica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Erythropoietin in polycystic kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Biological markers in the diagnosis of the different forms of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Identification of renox, an NAD(P)H oxidase in kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Higher target haemoglobin level and early anaemia treatment: different or complementary concepts?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Identification of the renal erythropoietin-producing cells using transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Risk factors and mortality associated with calciphylaxis in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900006-8

7 January 2021

10.1016/S0889-8529(01)00006-8

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12055983